| Trial Status | Recruiting |
| Dates | Date of activation: 18-Jul-11 |
| Data management at EORTC | Full |
| Phase | 3 |
| Randomized trial | Yes |
| Type | - |
| Targeted Sample size | EORTC Groups: 587 - All Groups: 587 |
| Number of steps | 2 |
| Drug | Pazopanib Blind trial medication |
| Study Staff | Mary O'Brien (Study Coordinator) - Royal Marsden Hospital - Sutton, Surrey, Sutton Baktiar Hasan (Statistician) - EORTC Headquarters, Brussels Marlies Dictus (Data Manager) - EORTC Headquarters, Brussels Athanasios Pallis (Coordinating Physician) - EORTC Headquarters, Brussels Benedicte Marchal (Project Manager) - EORTC Headquarters, Brussels, benedicte.marchal( at )eortc.be, +32 27741078 Gloria Montanes (Clinical Research Associate) - EORTC Headquarters, Brussels |
| Type of cancer | Lung |
| Participating Groups | EORTC Lung Cancer Group(Coordinating Group) |
| Centers authorized by EORTC | Clinique Andre Renard (Herstal, Belgium) - Inst. 9428 Universitair Ziekenhuis Gent (Gent, Belgium) - Inst. 104 Centre Hospitalier Regional De La Citadelle (Liege, Belgium) - Inst. 145 Clinique et Maternité Sainte Elisabeth (Namur, Belgium) - Inst. 1201 National Cancer Institute (Cairo, Egypt) - Inst. 8000 UniversitaetsMedizin Mannheim (Mannheim, Germany) - Inst. 527 Klinik Loewenstein (Loewenstein, Germany) - Inst. 9032 University General Hospital Heraklion (Heraklion, Greece) - Inst. 3610 University Clinic Golnik (Golnik, Slovenia) - Inst. 7650 The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, The Netherlands) - Inst. 301 Isala Klinieken - Locatie Weezenlanden (Zwolle, The Netherlands) - Inst. 329 Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital (Sheffield, United Kingdom) - Inst. 609 Christie NHS Foundation Trust (Manchester, United Kingdom) - Inst. 610 Royal Marsden Hospital - Chelsea, London (London, United Kingdom) - Inst. 613 Royal Marsden Hospital - Sutton, Surrey (Sutton, United Kingdom) - Inst. 616 Guy's and St Thomas' NHS - Guy's Hospital (London, United Kingdom) - Inst. 625 NHS Lothian - Western General Hospital (Edinburgh, United Kingdom) - Inst. 641 NHS Grampian - Aberdeen Royal Infirmary (Aberdeen, United Kingdom) - Inst. 642 King's Mill Hospital (Sutton-in-Ashfield, Nottinghamshire, United Kingdom) - Inst. 9063 NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom) - Inst. 6982 Nottingham University Hospitals NHS Trust - City Hospital campus (Nottingham, United Kingdom) - Inst. 6998 |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT01208064 |
| EudraCT | 2010-018566-23 |
| Protocol documents in PDF (requires password) | Study documentation |